Gelei Xiao

1.0k citations

53 papers · 731 indexed · h-index 18

Molecular Biology
Cancer Research top 10%
Cellular and Molecular Neuroscience top 10%
Physiology
Pulmonary and Respiratory Medicine

Co-authors: Yu-Chang Wang Xianrui Yuan Jian Yuan Shan Lv Jingping Liu Wenqing Xie Dingyang Liu Zhiping Zhang
Topics: Cerebrospinal fluid and hydrocephalus (18 papers)Fetal and Pediatric Neurological Disorders (12 papers)Traumatic Brain Injury and Neurovascular Disturbances (6 papers)
Cited by: Cancer Research Cellular and Molecular Neuroscience Neurology
Journals: SHILAP Revista de lepidopterologíaBiochemical and Biophysical Research Communications Electrochimica Acta
Partner nations: China United Kingdom United States

In The Last Decade

Gelei Xiao

46 papers receiving 721 citations

Peers

Countries citing papers authored by Gelei Xiao

Since Specialization

Citations

This map shows the geographic impact of Gelei Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gelei Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gelei Xiao more than expected).

Fields of papers citing papers by Gelei Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gelei Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gelei Xiao. The network helps show where Gelei Xiao may publish in the future.

Co-authorship network of co-authors of Gelei Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Gelei Xiao. A scholar is included among the top collaborators of Gelei Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gelei Xiao. Gelei Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circadian rhythm related genes signature in glioma for drug resistance prediction: a comprehensive analysis integrating transcriptomics and machine learning 2025 ·Discover Oncology ·(unknown),(unknown),(unknown),(unknown),(unknown),Gelei Xiao	0
2	Complex Hydrocephalus in Children: Procedure of Surgical Management 2025 ·(unknown),Junqiang Wang,(unknown),Zhikun Liu,Qian Ouyang,(unknown),Jun Huang,Gelei Xiao	0
3	Neutrophil Extracellular Trap Reprograms Cancer Metabolism to Form a Metastatic Niche Promoting Non‐Small Cell Lung Cancer Brain Metastasis 2025 ·Advanced Science ·Bo Chen,Karrie Mei Yee Kiang,Fangkun Liu,Chuntao Li,Xizhe Li,Weiwei Chen,Xin Fu,Gelei Xiao,(unknown),(unknown),(unknown),(unknown),Li Wang,Li Zhou,Tao Song,Longbo Zhang,Gkk Leung,Liyang Zhang	1
4	Zebrafish as a Model Organism for Congenital Hydrocephalus: Characteristics and Insights 2024 ·Zebrafish ·(unknown),Zhi Tang,(unknown),(unknown),Zhikun Liu,(unknown),Xuejun Li,Gelei Xiao	2
5	Simvastatin alleviates glymphatic system damage via the VEGF-C/VEGFR3/PI3K-Akt pathway after experimental intracerebral hemorrhage 2024 ·Brain Research Bulletin ·(unknown),(unknown),(unknown),(unknown),(unknown),Yibing Chen,(unknown),(unknown),Gelei Xiao	33
6	Oxidative stress in hydrocephalus: A new potential therapeutic target 2024 ·SHILAP Revista de lepidopterología ·Jie Zhao,Zhi Tang,Yali Jiang,(unknown),(unknown),(unknown),(unknown),Xiaoyu Chen,Gelei Xiao	0
7	Single-cell analysis identified PDIA3 as regulator of malignant characteristics and macrophage function in human cancers 2024 ·Functional & Integrative Genomics ·Wantao Wu,Gang Peng,(unknown),(unknown),Zhikun Liu,Gelei Xiao	0
8	The glymphatic system: A new insight into the understanding of neurological diseases 2024 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),Quan Cheng,(unknown),Yibing Chen,(unknown),(unknown),Zhi Tang,Gelei Xiao	3
9	Machine learning-based identification of SOX10 as an immune regulator of macrophage in gliomas 2022 ·Frontiers in Immunology ·Gelei Xiao,(unknown),Zeyu Wang,Ziyu Dai,Xisong Liang,Weijie Ye,Peng Luo,Jian Zhang,Zaoqu Liu,Quan Cheng,Renjun Peng	9
10	Research Progress on the Inflammatory Effects of Long Non-coding RNA in Traumatic Brain Injury 2022 ·Frontiers in Molecular Neuroscience ·Jianpeng Wang,Chong Li,(unknown),Gang Peng,Gelei Xiao,Rui Chen,Quan Cheng	7
11	Targeting choroid plexus epithelium as a novel therapeutic strategy for hydrocephalus 2022 ·Journal of Neuroinflammation ·(unknown),(unknown),Yu-Chang Wang,(unknown),(unknown),(unknown),Lei Tong,Gelei Xiao	14
12	Hydrocephalus after aneurysmal subarachnoid hemorrhage: Epidemiology, Pathogenesis, Diagnosis, and Management 2021 ·Signa Vitae ·Yu-Chang Wang,Xiaoqiang Wang,(unknown),(unknown),Zhi Tang,Zhiping Zhang,Jingping Liu,Gelei Xiao,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	5
13	MicroRNA-455–5p/CPEB1 pathway mediates Aβ-related learning and memory deficits in a mouse model of Alzheimer’s disease 2021 ·Brain Research Bulletin ·Gelei Xiao,Qianwei Chen,Xuewei Zhang	17
14	Novel therapeutics for hydrocephalus: Insights from animal models 2021 ·CNS Neuroscience & Therapeutics ·(unknown),Xiaoqiang Wang,(unknown),Yu-Chang Wang,Zhi Tang,Zhiping Zhang,Jingping Liu,Gelei Xiao	18
15	Airway epithelial integrin β4 suppresses allergic inflammation by decreasing CCL17 production 2020 ·Clinical Science ·Yuan Lin,Xun Zhang,Ming Yang,Xizi Du,Leyuan Wang,Shuangyan Wu,(unknown),(unknown),Gelei Xiao,Yizhou Zou,Yang Xiang,Xiangping Qu,Huijun Liu,Ling Qin,(unknown),Xiaoqun Qin,Chi Liu	14
16	Airway epithelial ITGB4 deficiency in early life mediates pulmonary spontaneous inflammation and enhanced allergic immune response 2020 ·Journal of Cellular and Molecular Medicine ·Sha Tang,Xizi Du,Yuan Lin,Gelei Xiao,(unknown),Leyuan Wang,Shuangyan Wu,(unknown),(unknown),Xiangping Qu,Huijun Liu,Yizhou Zou,Xiaoqun Qin,Ling Qin,Chi Liu	12
17	Xanthohumol suppresses glioblastoma via modulation of Hexokinase 2 -mediated glycolysis 2020 ·Journal of Cancer ·Jian Yuan,Gang Peng,Gelei Xiao,Zhuanyi Yang,Jun Huang,Qing Liu,(unknown),Dingyang Liu	24
18	Microsurgical Management of Craniopharyngiomas via a Unilateral Subfrontal Approach: A Retrospective Study of 177 Continuous Cases 2016 ·World Neurosurgery ·(unknown),Cheng-Yuan Feng,Xianrui Yuan,Qing Liu,(unknown),Xingjun Jiang,Xuejun Li,Gelei Xiao,Yifeng Li,Tao Xiong	17
19	Pituitary stalk management during the microsurgery of craniopharyngiomas 2014 ·Experimental and Therapeutic Medicine ·Gelei Xiao,Xianrui Yuan,Jian Yuan,(unknown),Yifeng Li,Cheng-Yuan Feng,Qing Liu,(unknown),Xuejun Li,(unknown)	19
20	miR-203 sensitizes glioma cells to temozolomide and inhibits glioma cell invasion by targeting E2F3 2014 ·Molecular Medicine Reports ·Guodong Tang,Jun Wu,Gelei Xiao,Lei Huo	12

About Gelei Xiao

Gelei Xiao is a scholar working on Cellular and Molecular Neuroscience, Pediatrics, Perinatology and Child Health and Neurology, having authored 53 papers that have together received 731 indexed citations. Recurring topics across this work include Cerebrospinal fluid and hydrocephalus (18 papers), Fetal and Pediatric Neurological Disorders (12 papers) and Traumatic Brain Injury and Neurovascular Disturbances (6 papers). The work is most often cited by research in Cancer Research (161 citations), Cellular and Molecular Neuroscience (141 citations) and Neurology (83 citations). Gelei Xiao has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Yu-Chang Wang, Xianrui Yuan, Jian Yuan, Shan Lv, Jingping Liu, Wenqing Xie, Dingyang Liu, Zhiping Zhang, Zhi Tang and Quan Cheng. Their work appears in journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Electrochimica Acta.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact